CN101125130A - Indian chrysanthemum effervescent preparation and preparation method thereof - Google Patents
Indian chrysanthemum effervescent preparation and preparation method thereof Download PDFInfo
- Publication number
- CN101125130A CN101125130A CNA200610109644XA CN200610109644A CN101125130A CN 101125130 A CN101125130 A CN 101125130A CN A200610109644X A CNA200610109644X A CN A200610109644XA CN 200610109644 A CN200610109644 A CN 200610109644A CN 101125130 A CN101125130 A CN 101125130A
- Authority
- CN
- China
- Prior art keywords
- acid
- consumption
- flos chrysanthemi
- chrysanthemi indici
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a wild chrysanthemum effervescent preparation and the preparation method, the preparation has simple and convenient production method as well as the low cost. The preparation has rapid dissolution, good efficacy, simple technique and low cost.
Description
Technical field
The present invention relates to a kind of pharmaceutical preparation, particularly relate to a kind of effervescent formulation that contains the Flos Chrysanthemi Indici effective ingredient and preparation method thereof.
Background technology
In clinical, no matter be Chinese medicine or Western medicine, many different types of antipyretic and antidotal type medicines are all arranged.Western medicine has some its prices expensive, and side reaction is many, and the clinical practice effect is not very good.Curative effect is comparatively satisfied and use more still based on Chinese medicine.
Flos Chrysanthemi Indici is clinical the most frequently used medicine always, has the effect of subduing swelling and detoxicating, wind and heat dispersing, infection, antiviral, and medicinal history among the people is long in China, and Chinese Pharmacopoeia also early records.Modern pharmacology proves: Flos Chrysanthemi Indici has effects such as broad-spectrum antiseptic, antiviral, blood pressure lowering, coronary blood flow increasing, removing oxygen-derived free radicals, and untoward reaction is few, action temperature and lasting, has higher medical value.
The chemical constituent that Flos Chrysanthemi Indici contains comprises terpenoid and volatile oil, is mainly monoterpenes, sesquiterpenoids and oxygen derivant thereof, triterpenoid compound, aliphatic compound etc.Also contain compositions such as flavone compound, chlorogenic acid and Glyceryl Behenate, Palmic acid, polysaccharide, beta-carotene, protein, aminoacid, purine, choline, stachydrine, tannin, vitamin, chlorophyll in addition.A kind of main active of Flos Chrysanthemi Indici is a chlorogenic acid, and the Sanitation Ministry medicine standard is included to have heat-clearing and toxic substances removing, 170 kinds of Chinese patent medicines of anti-inflammation all contain chlorogenic acid and be main component.
The Flos Chrysanthemi Indici in the different cultivars and the place of production all contains the various trace elements of needed by human, and the content of calcium, magnesium, ferrum is than the height in the Flos Chrysanthemi.The Flos Chrysanthemi Indici biological activity is various, delicate fragrance is pleasant, safe and reliable, simultaneously the medicine source is extensive, cheap, has wide development value in fields such as medicine, food, health product, cosmetics.
The present domestic common Flos Chrysanthemi Indici granule of having produced folk prescription, clinical practice prove, Flos Chrysanthemi Indici granule to furuncle swell and ache, conjunctival congestion and swelling pain, the dizzy therapeutic effect of headache be reliable, safe in utilization, is comparatively ideal medicine in the similar Chinese patent medicine, is subjected to the welcome of consumer deeply.
But existing Flos Chrysanthemi Indici granule preparation is only made by Flos Chrysanthemi Indici and two kinds of components of sucrose, does not have the production of effervescent granule, and its dosage form is single, makes vast patient have big limitation on selection of clinical.In addition, the shortcoming of existing common Flos Chrysanthemi Indici granule agent is that also brewing time is long, and solubility property is poor, needs when taking to dissolve granule with big water gaging, greatly reduces patient's compliance.Therefore press for a kind of new medicinal preparation of research and development, the clinical practice of being more convenient for.
Summary of the invention
Purpose of the present invention overcomes the deficiencies in the prior art exactly, and a kind of new medicinal preparation of Flos Chrysanthemi Indici is provided, and makes patient's selection more wide in range, with dash with usefulness, convenient and swift, be fit to very much modern life rhythm, be more suitable for clinical practice.
An object of the present invention is to provide a kind of Flos Chrysanthemi Indici effervescent formulation.
Another object of the present invention provides the preparation method of described Flos Chrysanthemi Indici effervescent formulation.
The inventor is through a large amount of research and repetition test, develops quick dissolving, curative effect excellence, technology Flos Chrysanthemi Indici effervescent formulation easy, with low cost and preparation method thereof.
Flos Chrysanthemi Indici effervescent formulation of the present invention contains following component:
Flos Chrysanthemi Indici 50～10000g
Filler such as lactose 20～100g
Disintegrating agent such as carboxymethylstach sodium 100～150g
Disintegrating agent such as low-substituted hydroxypropyl cellulose 50～80g
Lubricant (as Polyethylene Glycol) 200～350g
Acid 10～50g
Alkali 5～60g
Correctives such as cyclamate 10～30g
Dehydrated alcohol is an amount of
The invention further relates to preparing such formulations.In the development of this method, carried out the screening operation of adjuvant in the prescription, determine to select for use the adjuvant of forming, wherein said acid is selected from: citric acid, tartaric acid, fumaric acid, adipic acid, malic acid, rare ore deposit acid (example hydrochloric acid), water-soluble amino acid, acid salt (citric acid hydrogen dipotassium, potassium hydrogen tartrate, fumaric acid sodium etc.); Wherein said alkali is selected from: sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate etc.; Spendable filler is selected from the said preparation: starch, Icing Sugar, dextrin, lactose, microcrystalline Cellulose, mannitol; Described disintegrating agent is selected from: carboxymethylstach sodium, low-substituted hydroxypropyl cellulose, crospolyvinylpyrrolidone, cross-linking sodium carboxymethyl cellulose; Described lubricant is selected from: magnesium stearate, micropowder silica gel, Pulvis Talci, hydrogenated vegetable oil, Polyethylene Glycol; Described correctives is selected from: cyclamate, sucrose, stevioside, aspartame, xylitol.The sample of the side of Clicking here, process trial meets the requirement of quality standard through check.
The amount ratio of bronsted lowry acids and bases bronsted lowry is 0.6: 1～1: 1.2 in this prescription, and preferred proportioning is 0.8: 1～1: 1, and most preferred proportioning is 0.86: 1.
The consumption of preferred Flos Chrysanthemi Indici is 500～8000g in the Flos Chrysanthemi Indici effervescent formulation of the present invention, is more preferably 1500～5000g, most preferably is 2500～4500g, for example is 3000g.
Disintegrating agent is preferably 120～140g as the consumption of carboxymethyl starch sodium, is more preferably 125～135g.In addition, the consumption of disintegrating agent such as low-substituted hydroxypropyl cellulose is 55～75g preferably, more preferably 60～70g, most preferably 62.5～65g.
Can adopt acid in the effervescent formulation of the present invention, wherein the preferred 15～45g of Suan consumption, more preferably 15～40g, most preferably 20～30g, for example 25g.Used alkali for example is sodium bicarbonate, sodium carbonate, and the consumption of alkali is 10～50g preferably, more preferably 20～40g, 25～35g most preferably, 29g for example, 34g.
The preparation method of Flos Chrysanthemi Indici effervescent formulation of the present invention comprises the following steps:
1. get Flos Chrysanthemi Indici and added water retting 3 hours, decoct 3 times, each 1 hour of first and second time; 0.5 hour for the third time; Collecting decoction filters, and filtrate is concentrated into the clear paste that relative density is 1.15 (80 ℃), room temperature to be chilled to, add ethanol and make and contain alcohol amount and reach 60%, left standstill 24 hours, filter, filtrate recycling ethanol, being concentrated into relative density is the clear paste of 1.25 (80 ℃), drying under reduced pressure becomes dry extract (60～80 ℃);
2. after Flocdrysanthemi being ground into fine powder, mix, granulate, or granulate respectively, carry out drying in 50 ℃～80 ℃, promptly with dehydrated alcohol with appropriate amount of auxiliary materials.
3. the method for granulating respectively is for to granulate acid, alkali respectively, and dry again, mixing gets final product.
The formulation method of this product adopts preparation means conventional in the pharmaceutical field, and those skilled in the art can granulate according to the Professional knowledge of this area.
When this preparation carries out quality research, consider that Flos Chrysanthemi Indici belongs to monarch drug in this preparation, and prescription has only this medical material simply entirely, so decision is studied Flos Chrysanthemi Indici.Chlorogenic acid with Flos Chrysanthemi Indici is the assay index, and adopts the HPLC method to quantize examination.Methodological study is the result show, uses the content linear relationship of this method mensuration this product good, and repeatability, precision and response rate height have proved that this method mensuration this product content has feasibility.Test agent is all up to specification in the three batches of lab scales and three batches.
By working out method the chlorogenic acid in the test agent in three batches of lab scale samples and three batches is carried out assay, all more than the 2.30mg/ bag, with reference to officinal standard formulation method, so content limit is denoted as: this product contains chlorogenic acid for every bag must not be less than 2.30mg to the result.
The method of assay is to investigate by linear test, stability test, precision test, recovery test etc., proves that this method is used for measuring content, and method is feasible, and is quality controllable, meets the pharmacopeia regulation.
In stability study, test agent is pressed commercially available back in three batches, has carried out 12 months test under 25 ℃ ± 2 ℃ of temperature, relative humidity 60% ± 10% condition, and the result shows that every detection index all meets set quality standard and pharmacopeia regulation.Explanation under this terms of packing, preparation stabilization.
The specific embodiment
Following examples are in order further to describe the present invention for example, rather than limit the present invention by any way.
Embodiment 1:
1. get Flos Chrysanthemi Indici 3000g and added water retting 3 hours, decoct 3 times, each 1 hour of first and second time; 0.5 hour for the third time; Collecting decoction filters, and filtrate is concentrated into the clear paste that relative density is 1.15 (80 ℃), room temperature to be chilled to, add ethanol and make and contain alcohol amount and reach 60%, left standstill 24 hours, filter, filtrate recycling ethanol, being concentrated into relative density is the clear paste of 1.25 (80 ℃), drying under reduced pressure becomes dry extract (60～80 ℃);
2. after Flocdrysanthemi being ground into fine powder, mix with lactose 50g, carboxymethylstach sodium 125g, low-substituted hydroxypropyl cellulose 62.5g, Polyethylene Glycol 250g, cyclamate 25g, tartaric acid 25g, sodium bicarbonate 29g, granulate in right amount with dehydrated alcohol, carry out drying in 50 ℃～80 ℃, promptly.
Embodiment 2:
1. get Flos Chrysanthemi Indici 50g and added water retting 3 hours, decoct 3 times, each 1 hour of first and second time; 0.5 hour for the third time; Collecting decoction filters, and filtrate is concentrated into the clear paste that relative density is 1.15 (80 ℃), room temperature to be chilled to, add ethanol and make and contain alcohol amount and reach 60%, left standstill 24 hours, filter, filtrate recycling ethanol, being concentrated into relative density is the clear paste of 1.25 (80 ℃), drying under reduced pressure becomes dry extract (60～80 ℃);
2. after Flocdrysanthemi being ground into fine powder, mix with lactose 20g, carboxymethylstach sodium 135g, low-substituted hydroxypropyl cellulose 55g, magnesium stearate 200g, cyclamate 25g, citric acid 50g, sodium carbonate 60g, granulate in right amount with dehydrated alcohol, carry out drying in 50 ℃～80 ℃, promptly.
Embodiment 3:
1. according to embodiment 1 preparation Flocdrysanthemi, wherein the consumption of Flos Chrysanthemi Indici is 9800g,
2. the half with above-mentioned Flocdrysanthemi powder mixes with 100g carboxymethylstach sodium, 10g tartaric acid, 350 Pulvis Talci, with dehydrated alcohol system soft material, and oven dry in about 50 ℃
3. remaining Flocdrysanthemi powder and 8g sodium bicarbonate, 65g low-substituted hydroxypropyl cellulose, an amount of cyclamate are mixed, with dehydrated alcohol system soft material, oven dry in about 50 ℃
4. two kinds of granules are mixed, granulate, promptly.
In the official relevant solubility property test, Flos Chrysanthemi Indici effervescence granular preparation 300mg of the present invention only need or not stir and can all dissolve in 300 seconds with 30ml water, the plain particles preparation needs 150ml water, and constantly stirs down, needs the granule residue of dissolving in 300 seconds and residual 20%.
Existing Flos Chrysanthemi Indici granule preparation is made 1000 granular preparations by 333 gram Flos Chrysanthemi Indicis and 960 gram sucrose, and granular preparation of the present invention can be made by 3000 grams and about 600 gram effervescent adjuvants, this shows that the present invention contains several times (about 7～10 times) in the Flos Chrysanthemi Indici active component of plain particles preparation in the preparation of equal in quality, thereby reduced the required drug administration amount of patient, improved curative effect.In addition, because effervescent formulation solubility property of the present invention is good and the consumption minimizing, facilitates patients more and carry.
Claims (10)
1. method for preparing the Flos Chrysanthemi Indici effervescent formulation, this method may further comprise the steps:
1) gets Flos Chrysanthemi Indici and added water retting 3 hours, decoct 3 times, each 1 hour of first and second time; 0.5 hour for the third time; Collecting decoction filters, and filtrate is concentrated into the clear paste that relative density is 1.15 (80 ℃), room temperature to be chilled to, add ethanol and make and contain alcohol amount and reach 60%, left standstill 24 hours, filter, filtrate recycling ethanol, being concentrated into relative density is the clear paste of 1.25 (80 ℃), drying under reduced pressure becomes dry extract (60～80 ℃);
2) Flos Chrysanthemi Indici dry extract is ground into fine powder after, mix with appropriate amount of auxiliary materials, granulate with dehydrated alcohol, or substep granulates, carry out drying in 50 ℃～80 ℃, promptly;
3) the substep method of granulating is for to granulate acid, alkali respectively, drying again, mixing.Wherein the amount ratio of bronsted lowry acids and bases bronsted lowry is 0.6: 1～1: 1.2.
2. the described method of claim 1, the consumption proportion of wherein said acid and alkali is 0.8: 1～1: 1; Described acid is selected from one or more of citric acid, tartaric acid, fumaric acid, adipic acid, malic acid, the acid of rare ore deposit, water-soluble amino acid, acid salt; Wherein said alkali is selected from: one or more of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate; Spendable filler is selected from the said preparation: starch, Icing Sugar, dextrin, lactose, microcrystalline Cellulose, mannitol; Described disintegrating agent is selected from: carboxymethylstach sodium, low-substituted hydroxypropyl cellulose, crospolyvinylpyrrolidone, cross-linking sodium carboxymethyl cellulose; Described lubricant is selected from: magnesium stearate, micropowder silica gel, Pulvis Talci, hydrogenated vegetable oil, Polyethylene Glycol.
3. the described method of claim 2, the consumption proportion of wherein said acid and alkali is 0.86: 1.
4. by the Flos Chrysanthemi Indici effervescent formulation of each described method preparation of claim 1～3.
5. the described Flos Chrysanthemi Indici effervescent formulation of claim 4, wherein the consumption of Flos Chrysanthemi Indici is 2500～4500g, and the consumption of carboxymethyl starch sodium is 125～135g, and the consumption of low-substituted hydroxypropyl cellulose is 62.5～65g, the consumption of acid is 20～30g, and the consumption of alkali is 25～35g.
6. Flos Chrysanthemi Indici effervescent formulation:
Flos Chrysanthemi Indici 50～10000g
Lactose 20～100g
Disintegrating agent 150～230g
Macrogol 200～350g
Tartaric acid 10～50g
Sodium bicarbonate 5～60g
Cyclamate 10～30g
Dehydrated alcohol is an amount of.
7. the effervescent formulation of claim 6, wherein the consumption of Flos Chrysanthemi Indici is 2500～4500g, the consumption of carboxymethyl starch sodium is 125～135g, the consumption of low-substituted hydroxypropyl cellulose is 62.5～65g, the consumption of acid is 20～30g, the consumption of alkali is 25～35g, and described acid is selected from one or more of citric acid, tartaric acid, fumaric acid, adipic acid, malic acid, the acid of rare ore deposit, water-soluble amino acid, acid salt; Wherein said alkali is selected from: one or more of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate.
8. claim 6 or 7 each described effervescent formulations, wherein the consumption of Flos Chrysanthemi Indici is 3000g, and tartaric consumption is 25g, and the consumption of sodium bicarbonate is 29g, and the consumption of carboxymethyl starch sodium is 125g, Polyethylene Glycol is 250g.
9. claim 6 or 7 each described Flos Chrysanthemi Indici effervescent formulations, wherein alkali is sodium bicarbonate or sodium carbonate, and described acid is tartaric acid or citric acid, and wherein said preparation is an effervescence granular preparation.
10. claim 6 or 7 each described Flos Chrysanthemi Indici effervescent formulations, wherein the consumption of Flos Chrysanthemi Indici is 3000g, and tartaric consumption is 25g, and the consumption of sodium bicarbonate is 29g, and the consumption of carboxymethyl starch sodium is 125g, Polyethylene Glycol is 250g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610109644XA CN101125130B (en) | 2006-08-14 | 2006-08-14 | Indian chrysanthemum effervescent preparation and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200610109644XA CN101125130B (en) | 2006-08-14 | 2006-08-14 | Indian chrysanthemum effervescent preparation and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101125130A true CN101125130A (en) | 2008-02-20 |
| CN101125130B CN101125130B (en) | 2010-12-22 |
Family
ID=39093323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200610109644XA Expired - Fee Related CN101125130B (en) | 2006-08-14 | 2006-08-14 | Indian chrysanthemum effervescent preparation and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101125130B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4061B1 (en) * | 2009-02-20 | 2010-07-31 | Николае Павел КОВАЛЕНКО | Cooler for luminaire with light-emitting diodes |
| CN102188469A (en) * | 2011-05-27 | 2011-09-21 | 河南大学 | Chrysanthemum morifolium extractive with live protection function, extraction method and applications thereof |
| CN106265833A (en) * | 2016-08-01 | 2017-01-04 | 遵义医学院 | A kind of Flos Lonicerae effervescent tablet and preparation method thereof |
| CN107242556A (en) * | 2017-05-25 | 2017-10-13 | 四川农业大学 | A kind of dual-purpose FLOS CHRYSANTHEMI ALBA from Haizhou of China lozenge and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1215861C (en) * | 2002-12-27 | 2005-08-24 | 中山大学 | Xiasangju effervescent tablet and its preparing process |
| CN100496515C (en) * | 2004-05-21 | 2009-06-10 | 江西本草天工科技有限责任公司 | Ring form effervescence dosage and preparation method thereof |
| CN1277550C (en) * | 2004-07-23 | 2006-10-04 | 张晴龙 | Wild chrysanthemum oral disintegration tablet and its preparing method |
-
2006
- 2006-08-14 CN CN200610109644XA patent/CN101125130B/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4061B1 (en) * | 2009-02-20 | 2010-07-31 | Николае Павел КОВАЛЕНКО | Cooler for luminaire with light-emitting diodes |
| CN102188469A (en) * | 2011-05-27 | 2011-09-21 | 河南大学 | Chrysanthemum morifolium extractive with live protection function, extraction method and applications thereof |
| CN106265833A (en) * | 2016-08-01 | 2017-01-04 | 遵义医学院 | A kind of Flos Lonicerae effervescent tablet and preparation method thereof |
| CN107242556A (en) * | 2017-05-25 | 2017-10-13 | 四川农业大学 | A kind of dual-purpose FLOS CHRYSANTHEMI ALBA from Haizhou of China lozenge and preparation method thereof |
| CN107242556B (en) * | 2017-05-25 | 2021-03-23 | 四川农业大学 | Dual-purpose chrysanthemum morifolium ramat buccal tablets and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101125130B (en) | 2010-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3875100A1 (en) | Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation | |
| CN101125130B (en) | Indian chrysanthemum effervescent preparation and preparation method thereof | |
| CN100556401C (en) | Effervescence tablet for cold | |
| CN110882168A (en) | Effervescent tablet, preparation method and application thereof | |
| CN114377105A (en) | Baoyuan effervescent tablet and preparation method and application thereof | |
| CN102085344B (en) | Aplotaxis carminative sustained-release preparation and preparation method thereof | |
| RU2605271C1 (en) | Granules with extracts of cranberries, red bilberry madder antidiuretic, antispasmodic and litholytic action | |
| CN105476971A (en) | Medical composition for treating cold and preparation method of medical composition | |
| RU2563190C2 (en) | Medication based on dry extracts of medicinal plants and method of obtaining thereof (versions) | |
| CN101703690A (en) | Medicament for treating metrorrhagia and metrostaxis, hematemesis, hematochezia and traumatic hemorrhage and preparation method thereof | |
| CN100496515C (en) | Ring form effervescence dosage and preparation method thereof | |
| CN102836138A (en) | Paracetamol vitamin C effervescent tablet and preparation process thereof | |
| CN105687186A (en) | Sleeping medicinal preparation for external use and preparation method thereof | |
| CN100556426C (en) | Anti-bone regeneration preparation and the method for making and the detection method of treatment orthopaedic disease | |
| RU2182011C1 (en) | Biologically active food additive to prevent reduction of immune system | |
| CN101239145A (en) | 'Gualou Xiebai Guizhi' oral preparation and preparation thereof | |
| CN102114009A (en) | Pharmaceutical composition containing tomoxetine and preparation method thereof | |
| CN106943390B (en) | Application of the Strychnos nux-vomica aglycon in preparation prevention or treatment antiarrhythmic medicament | |
| CN101003829A (en) | Polypeptide of seed of spine date, preparation method, and application | |
| CN115317508B (en) | Private effervescent tablet for external use and preparation method thereof | |
| JP3967767B1 (en) | Method for producing intraoral rapidly disintegrating tablet | |
| JP3545512B2 (en) | Effervescent tablets containing crude drugs | |
| CN109662235A (en) | A kind of selenium-enriched fruit and vegetable effervescent tablet and preparation method thereof | |
| CN103202972B (en) | Pediatric effervescent tablets | |
| CN100551361C (en) | Influenza defervesce effervescent tablet and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: XINLIFEI BIOPHARMACEUTICAL TECHNOLOGY (TIANJIN) CO Free format text: FORMER OWNER: BEIJING SIHUANKEBAO PHARMACEUTICAL CO., LTD. Effective date: 20110615 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100070 NO. 11, HAIYING ROAD, FENGTAI SCIENCE PARK, BEIJING TO: 300457 S1316, 13/F, LAB BUILDING, TIANJIN INTERNATIONAL JOINT ACADEMY OF BIOTECHNOLOGY, NO. 220, DONGTING ROAD, TIANJIN DEVELOPMENT ZONE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110615 Address after: 300457 Tianjin Development Zone, 220 Dongting Road, Tianjin International Biological union laboratory building, thirteen floor, S1316 Patentee after: Bio Pharmaceutical Technology (Tianjin) Co., Ltd. Address before: 100070 Beijing science and Technology Park of Fengtai Haiying Road No. 11 Patentee before: Beijing Sihuankebao Pharmaceutical Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 Termination date: 20180814 |